A Multi-Center, Open-Label, Single Administration, Sequential Dose Escalation of BIW-8405/MEDI-563 in Subjects With Mild Asthma
Phase of Trial: Phase I
Latest Information Update: 26 Nov 2008
At a glance
- Drugs Benralizumab (Primary)
- Indications Asthma
- Focus Adverse reactions
- 26 Nov 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Oct 2008 Interim results were reported at the European Respiratory Society meeting.
- 05 Oct 2008 Status changed from recruiting to active, no longer recruiting, based on information from ClinicalTrials.gov.